<DOC>
	<DOCNO>NCT00572234</DOCNO>
	<brief_summary>Methamphetamine dependence significant drug use disorder Midwest . While number psychosocial pharmacological treatment study , specific treatment methamphetamine identify . This study collaborative pre-clinical clinical partnership examine bupropion treatment methamphetamine dependence .</brief_summary>
	<brief_title>Bupropion Treatment Methamphetamine Dependence</brief_title>
	<detailed_description>Nearly 40 % adult seek substance use disorder ( SUD ) treatment Nebraska report methamphetamine drug choice . In preliminary study examine bupropion methamphetamine use , well tolerate , reduce crave methamphetamine reduce methamphetamine relate euphoria . Investigators University Nebraska Medical Center University Nebraska-Lincoln initiated study examine bupropion animal humans potential intervention addictive disorder . Pre-clinical study Co-Investigator 's laboratory first demonstrate potential utility bupropion pharmacotherapy methamphetamine use disorder ( MUD ) Principal Investigator study bupropion smoke cessation aid alcoholic . The primary goal study establish interdisciplinary translational collaboration test bupropion person treatment methamphetamine dependence inform pre-clinical study enhance practical applicability clinical setting . The pilot clinical study examine treatment effect safety 12 week course bupropion person methamphetamine use disorder . Concurrently , examine efficacy bupropion methamphetamine self-administration animal model well simulates clinical approach .</detailed_description>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>patient substance use disorder program either Omaha VA Medical Center Catholic Charities Campus Hope diagnosis methamphetamine dependence well presence history psychosis base Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) criterion ( include patient full sustained remission ) provide name , address , phone number least two collateral informant provide information methamphetamine drug use followup must sign informed consent approve UNMC IRB Catholic Charities Research Committee . history severe injury brain advance cardiac , pulmonary , renal liver disease predisposition seizures history bulimia anorexia nervosa current diagnosis major depressive disorder diagnosis past history panic disorder , schizophrenia , bipolar affective disorder family history childhood history epilepsy seizures history stroke , brain tumor , bleed brain . used psychoactive drug within one week study entry ( two week MAO inhibitor protriptyline , four week fluoxetine ) currently use theophylline product ( e.g . Theodur ) use investigational drug study within past four week use therapeutic course bupropion SR &gt; 1 week time past 12 month evaluate previous study examine bupropion SR anytime If female , participant must pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Methamphetamine</keyword>
	<keyword>Bupropion SR</keyword>
</DOC>